CIK: 0001582844 · Show all filings
Period: Q4 2022 (← Previous) (Next →)
Filing Date: Feb 14, 2023
Total Value ($000): $162,501 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WHWK | AADI BIOSCIENCES INC | 1,849,402 | $19,622 | 12.1% | $27.48 | -52.5% | COM | 00032Q104 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 396,500 | $11,582 | 7.1% | $17.88 | +28.8% | COM | 92790C104 |
| APLS | APELLIS PHARMACEUTICALS INC | 217,500 | $11,247 | 6.9% | $38.98 | +36.1% | COM | 03753U106 |
| TERN | TERNS PHARMACEUTICALS INC | 1,100,000 | $11,198 | 6.9% | $5.72 | +16.4% | COM | 880881107 |
| UTHR | UNITED THERAPEUTICS CORP DEL | 33,000 | $9,177 | 5.6% | $220.39 | +14.5% | COM | 91307C102 |
| SRPT | SAREPTA TEHRAPEUTICS INC | 67,500 | $8,747 | 5.4% | $106.61 | +8.7% | COM | 803607100 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 324,614 | $8,261 | 5.1% | $19.57 | +19.2% | COM | 87164F105 |
| — | IVERIC BIO INC | 360,500 | $7,718 | 4.7% | $7.63 | — | COM | 46583P102 |
| VTYX | VENTYX BIOSCIENCES INC | 290,500 | $7,558 | 4.7% | $21.58 | +37.3% | COM | 92332V107 |
| PCVX | VAXCYTE INC | 144,500 | $6,929 | 4.3% | $31.07 | +26.3% | COM | 92243G108 |
| — | CYMABAY THERAPEUTICS INC. COMMON STOCK | 1,015,000 | $6,364 | 3.9% | $6.27 | — | COM | 23257D103 |
| KURA | KURA ONCOLOGY INC. COMMON STOCK | 501,500 | $6,224 | 3.8% | $15.03 | -3.3% | COM | 50127T109 |
| — | MERSANA THERAPEUTICS INC | 950,000 | $5,567 | 3.4% | $5.86 | — | COM | 59045L106 |
| — | BELLUS HEALTH INC | 632,500 | $5,199 | 3.2% | $8.20 | — | COM NEW | 07987C204 |
| CLDX | CELLDEX THERAPEUTICS INC | 115,000 | $5,126 | 3.2% | $7.56 | +372.3% | COM NEW | 15117B202 |
| RCKT | ROCKET PHARMACEUTICALS INC | 260,000 | $5,088 | 3.1% | $18.42 | 0.0% | COM | 77313F106 |
| BCAB | BIOATLA INC | 500,000 | $4,125 | 2.5% | $6.55 | +26.7% | COM | 09077B104 |
| ACRS | ACLARIS THERAPEUTICS | 255,000 | $4,016 | 2.5% | $16.22 | -0.8% | COM | 00461U105 |
| KROS | KEROS THERAPEUTICS INC | 80,000 | $3,842 | 2.4% | $46.71 | 0.0% | COM | 492327101 |
| GHRS | GH RESEARCH PLC | 243,250 | $2,364 | 1.5% | $20.48 | -47.2% | ORDINARY SHARES | G3855L106 |
| ARGX | ARGEN SE | 5,100 | $1,932 | 1.2% | $378.83 | — | SPONSORED ADR | 04016X101 |
| ARWR | ARROWHEAD PHARMACEUTICALS INC | 41,029 | $1,664 | 1.0% | $42.29 | -21.6% | COM | 04280A100 |
| FULC | FULCRUM THERAPEUTICS INC | 185,000 | $1,347 | 0.8% | $11.30 | -42.3% | COM | 359616109 |
| PMVP | PMV PHARMACEUTICALS INC | 154,471 | $1,344 | 0.8% | $17.26 | -38.2% | COM | 69353Y103 |
| EYPT | EYEPOINT PHARMACEUTICALS INC | 303,396 | $1,062 | 0.7% | $11.19 | -60.6% | COM NEW | 30233G209 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 153,639 | $982 | 0.6% | $19.89 | -60.8% | COM | 462260100 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 93,500 | $982 | 0.6% | $8.89 | 0.0% | CLASS A ORD | 61559X104 |
| PYXS | PYXIS ONCOLOGY INC | 669,158 | $897 | 0.6% | $5.29 | -71.6% | COMMON STOCK | 747324101 |
| RZLT | REZOLUTE INC | 420,000 | $869 | 0.5% | $3.32 | -43.7% | COM NEW | 76200L309 |
| — | HORIZON THERAPEUTICS PLC | 6,000 | $683 | 0.4% | $106.80 | — | SHS | G46188101 |
| PRTA | PROTHENA CORPORATION PLC | 9,300 | $560 | 0.3% | $58.56 | 0.0% | SHS | G72800108 |
| — | IMARA INC | 44,503 | $182 | 0.1% | $4.09 | — | COM | 45249V107 |
| — | KINNATE BIOPHARMA INC | 5,000 | $31 | 0.0% | $12.00 | — | COM | 49705R105 |
| — | NUVATION BIO INC | 90,832 | $13 | 0.0% | $0.28 | — | *W EXP 07/07/2027 | 67080N119 |